Summary Kiromic Inc (Kiromic) is a biotechnology company focused on developing immuno-oncology therapies.Its pipeline products include BSK01, an injectable drug that harness dendritic cells for the treatment of solid and hematological malignancies; BSK02, a synthetic oral cancer immunotherapy compound used to treat solid tumors.
The company utilizes artificial intelligence disease-specific antigen discovery platform (KAI-BLADE), and drug development programs across multiple technology platforms including cellular therapies, TCR therapy, and CAR-T therapy, oral immunotherapy, and gene therapy.Kiromic’s Oral Delivery Platform (ODP) consists of synthetic and biocompatible microparticles that include cancer-specific immunotargets, immuno-stimulatory compounds, and lymphatic system targeting moieties that enhance the immunogenic response against cancer cells.
The company works in collaboration with other research universities and advisory companies in the US. Kiromic is headquartered in Houston, Texas, the US.
Kiromic Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
Interleukin 1 - Pipeline Review, H2 2020 Summary Interleukin 1 (IL1) pipeline Target constitutes close to 30 molecules. Out of which approximately 29 molecules are developed by companies and remaining by the universities/institutes. The latest report Interleukin 1 - Pipeline Review, H2 2020, outlays...
“CAR-T – Pipeline Insight, 2020,” report provides comprehensive insights about 250+ companies and 250+ pipeline drugs in CAR-T pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule...
Lysosomal Alpha Glucosidase - Pipeline Review, H2 2020 Summary Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 126.96.36.199) - Lysosomal alpha-glucosidase is an enzyme encoded by the GAA gene. It is essential for the degradation of glygogen to glucose in lysosomes. Defects...
Turner Syndrome Global Clinical Trials Review, H1, 2020 Summary Clinical trial report, “Turner Syndrome Global Clinical Trials Review, H1, 2020" provides an overview of Turner Syndrome Clinical trials scenario.This report provides top line data relating to the clinical trials on Turner Syndrome. Report...
Wound Closure Devices - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Wound Closure Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Wound Closure Devices pipeline products with comparative analysis of the products...
Smallpox - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Smallpox - Pipeline Review, H2 2020, provides an overview of the Smallpox (Infectious Disease) pipeline landscape. Smallpox is an acute contagious infection caused by the Variola virus....